Search results

Order by most recent / most popular / relevance

Results: 1-6 of 6

Monsanto v. Cefetra: the future of biotech patent protection in Europe?

NautaDutilh
-
European Union, Netherlands
-
March 9 2010

Today, Advocate General Mengozzi has rendered his opinion in the much debated Monsanto v. Cefetra case (C-42808

'Round up' on the scope of DNA patents - Monsanto Technology LLC v Cefetra BV and others

Wragge & Co LLP
-
European Union, Netherlands
-
March 17 2010

Since their inception, DNA sequence patents have proved a hot topic in patent law

Inclusion in the G-Standard of a generic medicine held not to be infringing

Bird & Bird
-
Netherlands
-
August 20 2007

In Glaxo Group Ltd v. Pharmachemie B.V., the District Court of The Hague was asked to consider the question whether the inclusion of the generic medicine Ondansetron in the so-called ‘G-Standard’ prior to the expiry of the patent protection (of a second medical use of) this medicine constituted patent infringement

The ECJ confirms that a supplementary protection certificate (SPC) can be granted irrespective of an existing SPC that has been granted to another patentee for the same 'product'

Herbert Smith Freehills LLP
-
European Union, Netherlands
-
September 4 2009

The ECJ judgment in AHP Manufacturing BV v Bureau voor de Industriële Eigendom (Case C-48207), following a reference by the Dutch Courts, clarifies the scope of Article 3(c) of the SPC Regulations (previously, and at the time of referral to the ECJ, Regulation 176892 but now Regulation 4692009

The Lundbeck cases; different decision on validity patent in different European countries

De Brauw Blackstone Westbroek
-
Germany, Netherlands, United Kingdom
-
July 31 2009

What is interesting about the Lundbeck cases is that Lundbeck initiated several patent infringement cases in Europe (in the Netherlands, Germany and in the UK) and that each court decided differently on the validity of the Lundbeck patent

Customs seizures of generic medicines

Bird & Bird
-
Netherlands
-
December 15 2009

As reported earlier in relation to customs seizures based on Anti Piracy Regulation 13832003, Dutch Courts, including the Supreme Court, have often applied a legal fiction to cases concerning the transit of goods through The Netherlands

Search results

Monsanto v. Cefetra: the future of biotech patent protection in Europe?

'Round up' on the scope of DNA patents - Monsanto Technology LLC v Cefetra BV and others

Inclusion in the G-Standard of a generic medicine held not to be infringing

The ECJ confirms that a supplementary protection certificate (SPC) can be granted irrespective of an existing SPC that has been granted to another patentee for the same 'product'

The Lundbeck cases; different decision on validity patent in different European countries

Customs seizures of generic medicines

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction